scholarly journals Long-term effect of bosentan in pulmonary hypertension associated with complex congenital heart disease

2013 ◽  
Vol 32 (2) ◽  
pp. 123-129 ◽  
Author(s):  
Rui Baptista ◽  
Graça Castro ◽  
António Marinho da Silva ◽  
Pedro Monteiro ◽  
Luís Augusto Providência
Keyword(s):  
Congenital Heart Disease ◽  
Pulmonary Hypertension ◽  
Heart Disease ◽  
Congenital Heart ◽  
Term Effect ◽  
Complex Congenital Heart Disease ◽  
Long Term Effect

scholarly journals Long-term effect of bosentan in pulmonary hypertension associated with complex congenital heart disease

2013 ◽  
Vol 32 (2) ◽  
pp. 123-129
Author(s):  
Rui Baptista ◽  
Graça Castro ◽  
António Marinho da Silva ◽  
Pedro Monteiro ◽  
Luís Augusto Providência
Keyword(s):  
Congenital Heart Disease ◽  
Pulmonary Hypertension ◽  
Heart Disease ◽  
Congenital Heart ◽  
Term Effect ◽  
Complex Congenital Heart Disease ◽  
Long Term Effect

Long-Term Bosentan Treatment of Complex Congenital Heart Disease and Eisenmenger's Syndrome

2009 ◽  
Vol 62 (9) ◽  
pp. 1046-1049 ◽  
Author(s):  
Eva Díaz-Caraballo ◽  
Ana E. González-García ◽  
Margarita Reñones ◽  
Ángel Sánchez-Recalde ◽  
Francisco García-Río ◽  
...  
Keyword(s):  
Congenital Heart Disease ◽  
Heart Disease ◽  
Congenital Heart ◽  
Complex Congenital Heart Disease ◽  
Eisenmenger’S Syndrome

Long-Term Results After Extracardiac Valved Conduits Implanted for Complex Congenital Heart Disease

1988 ◽  
Vol 3 (4) ◽  
pp. 495-500 ◽  
Author(s):  
ANTONIA CORNO ◽  
ALESSANDRO GIAMBERTI ◽  
SALVATORE GIANNICO ◽  
BRUNO MARINO ◽  
SERGIO PICARDO ◽  
...  
Keyword(s):  
Congenital Heart Disease ◽  
Heart Disease ◽  
Congenital Heart ◽  
Long Term Results ◽  
Complex Congenital Heart Disease

Surgery for Congenital Heart Disease: Improvements in Outcomes

2018 ◽  
Vol 35 (06) ◽  
pp. 557-560 ◽  
Author(s):  
Richard Jonas ◽  
Gerard Martin
Keyword(s):  
Congenital Heart Disease ◽  
Heart Disease ◽  
Congenital Heart ◽  
Complex Congenital Heart Disease ◽  
Term Outcome ◽  
Term Survival ◽  
Younger Age ◽  
Care Outcomes ◽  
Moderate Complexity

AbstractCardiac surgery for congenital heart disease has changed dramatically since the first surgery in 1938. During the early era, children underwent surgery at older ages often with palliative procedures before their corrective operation. Not surprisingly, in the early era, there was considerably higher early and late mortality, including the additive risks of having more than one procedure and a long period of living with an unphysiological palliated circulation. Over time with advances in noninvasive diagnosis, surgical approach, cardiopulmonary bypass techniques, and team-based care, outcomes have improved. Children now undergo corrective surgery at a younger age and have fewer palliative procedures. Short-term outcome as measured by the commonly used metric “procedural early mortality” (i.e., death before hospital discharge or less than 30 days following a surgical procedure) is now as low as 1 or 2% for many low-to-moderate complexity procedures. Late outcomes have also improved with long-term survival of hospital survivors for simple lesions being close to population controls. Late outcomes for more complex defects still show diminishing survival relative to a control population. Examination of the causes of death provides insights into areas in which clinical improvements may further improve the outlook for children with complex congenital heart disease.

Sign in / Sign up

Export Citation Format

Share Document